Nilay Vora
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Nilay Vora has a total of 41 co-authors. Here are the top co-authors by number of shared publications:
- Irene Georgakoudi
Tufts Unive
5 shared publications - Abani Patra
Data Intensive Studies Center, Tufts University, Medford, MA 02155, USA
4 shared publications Michael Esmail
Tufts Comparative Medicine Services, Tufts University, Medford, MA, 02155, USA
3 shared publicationsAbani Patra
Data Intensive Studies Center, Tufts University, Medford, MA, 02155, USA
2 shared publications- Christopher M. Polleys
Department of Biomedical Engineering, Tufts University
2 shared publications - Elizabeth M. Genega
Tufts University School of Medicine, Tufts Medical Center, Department of Pathology and Laboratory Medicine, Boston, Massachusetts, United States
2 shared publications
Latest Publications
- Open Access
- 17 December 2025
- Published by Springer Nature in Communications Biology
- Vol. 9 (1)
Cross-species validation of a human age-related hearing loss candidate KLHDC7B as essential for mammalian hearing
Although age-related hearing loss (ARHL) is the most common sensory loss in older adults, underlying mechanisms remain unclear. Recent genome-wide association studies (GWAS) linked variation in several genes with ARHL risk, including KLHDC7B , a gene of unknown function not previously linked to hearing. We demonstrate Klhdc7b is expressed exclusively in sensory hair cells in mouse cochlea. Utilizing two independent mouse knockout models ( Klhdc7b IMPC-/- and Klhdc7b Regn Δ/Δ ) we find that absence of Klhdc7b leads to severe early-onset, progressive hearing loss. Hair cells appear to develop normally, but outer hair cells are progressively lost from base-to-apex of the cochlea, a common pathology in ARHL. These results suggest KLHDC7B is required for maintenance rather than development, of auditory function. The validation in mouse of a human ARHL GWAS association suggests other novel candidates should be investigated. Our work provides two mouse models to study KLHDC7B function, and for development of therapeutic tools for ARHL.
- 17 December 2025
- Published by Springer Nature in Communications Biology
- Vol. 9 (1)
Open AccessCross-species validation of a human age-related hearing loss candidate KLHDC7B as essential for mammalian hearing
Although age-related hearing loss (ARHL) is the most common sensory loss in older adults, underlying mechanisms remain unclear. Recent genome-wide association studies (GWAS) linked variation in several genes with ARHL risk, including KLHDC7B , a gene of unknown function not previously linked to hearing. We demonstrate Klhdc7b is expressed exclusively in sensory hair cells in mouse cochlea. Utilizing two independent mouse knockout models ( Klhdc7b IMPC-/- and Klhdc7b Regn Δ/Δ ) we find that absence of Klhdc7b leads to severe early-onset, progressive hearing loss. Hair cells appear to develop normally, but outer hair cells are progressively lost from base-to-apex of the cochlea, a common pathology in ARHL. These results suggest KLHDC7B is required for maintenance rather than development, of auditory function. The validation in mouse of a human ARHL GWAS association suggests other novel candidates should be investigated. Our work provides two mouse models to study KLHDC7B function, and for development of therapeutic tools for ARHL.
- Open Access
- 8 March 2024
- Published by Royal Society of Chemistry (RSC) in Lab on a Chip
- Vol. 24 (8) , 2237-2252
Deep learning-enabled detection of rare circulating tumor cell clusters in whole blood using label-free, flow cytometry
We present a deep-learning enabled, label-free flow cytometry platform for identifying circulating tumor cell clusters in whole blood based on the endogenous scattering detected at three wavelengths. The method has potential for in vivo translation.
- 8 March 2024
- Published by Royal Society of Chemistry (RSC) in Lab on a Chip
- Vol. 24 (8) , 2237-2252
Open AccessDeep learning-enabled detection of rare circulating tumor cell clusters in whole blood using label-free, flow cytometry
We present a deep-learning enabled, label-free flow cytometry platform for identifying circulating tumor cell clusters in whole blood based on the endogenous scattering detected at three wavelengths. The method has potential for in vivo translation.
- Open Access
- 1 December 2023
- Published by SPIE-Intl Soc Optical Eng in Journal of Biomedical Optics
- Vol. 28 (12) , 126006-21
Restoration of metabolic functional metrics from label-free, two-photon human tissue images using multiscale deep-learning-based denoising algorithms
SignificanceLabel-free, two-photon excited fluorescence (TPEF) imaging captures morphological and functional metabolic tissue changes and enables enhanced understanding of numerous diseases. However, noise and other artifacts present in these images severely complicate the extraction of biologically useful information.AimWe aim to employ deep neural architectures in the synthesis of a multiscale denoising algorithm optimized for restoring metrics of metabolic activity from low-signal-to-noise ratio (SNR), TPEF images.ApproachTPEF images of reduced nicotinamide adenine dinucleotide (phosphate) (NAD(P)H) and flavoproteins (FAD) from freshly excised human cervical tissues are used to assess the impact of various denoising models, preprocessing methods, and data on metrics of image quality and the recovery of six metrics of metabolic function from the images relative to ground truth images.ResultsOptimized recovery of the redox ratio and mitochondrial organization is achieved using a novel algorithm based on deep denoising in the wavelet transform domain. This algorithm also leads to significant improvements in peak-SNR (PSNR) and structural similarity index measure (SSIM) for all images. Interestingly, other models yield even higher PSNR and SSIM improvements, but they are not optimal for recovery of metabolic function metrics.ConclusionsDenoising algorithms can recover diagnostically useful information from low SNR label-free TPEF images and will be useful for the clinical translation of such imaging.
- 1 December 2023
- Published by SPIE-Intl Soc Optical Eng in Journal of Biomedical Optics
- Vol. 28 (12) , 126006-21
Open AccessRestoration of metabolic functional metrics from label-free, two-photon human tissue images using multiscale deep-learning-based denoising algorithms
SignificanceLabel-free, two-photon excited fluorescence (TPEF) imaging captures morphological and functional metabolic tissue changes and enables enhanced understanding of numerous diseases. However, noise and other artifacts present in these images severely complicate the extraction of biologically useful information.AimWe aim to employ deep neural architectures in the synthesis of a multiscale denoising algorithm optimized for restoring metrics of metabolic activity from low-signal-to-noise ratio (SNR), TPEF images.ApproachTPEF images of reduced nicotinamide adenine dinucleotide (phosphate) (NAD(P)H) and flavoproteins (FAD) from freshly excised human cervical tissues are used to assess the impact of various denoising models, preprocessing methods, and data on metrics of image quality and the recovery of six metrics of metabolic function from the images relative to ground truth images.ResultsOptimized recovery of the redox ratio and mitochondrial organization is achieved using a novel algorithm based on deep denoising in the wavelet transform domain. This algorithm also leads to significant improvements in peak-SNR (PSNR) and structural similarity index measure (SSIM) for all images. Interestingly, other models yield even higher PSNR and SSIM improvements, but they are not optimal for recovery of metabolic function metrics.ConclusionsDenoising algorithms can recover diagnostically useful information from low SNR label-free TPEF images and will be useful for the clinical translation of such imaging.
- Open Access
Deep Learning-Enabled, Detection of Rare Circulating Tumor Cell Clusters in Whole Blood Using Label-free, Flow Cytometry
Metastatic tumors have poor prognoses for progression-free and overall survival for all cancer patients. Rare circulating tumor cells (CTCs) and rarer circulating tumor cell clusters (CTCCs) are potential biomarkers of metastatic growth, with CTCCs representing an increased risk factor for metastasis. Current detection platforms are optimized for ex vivo detection of CTCs only. Microfluidic chips and size exclusion methods have been proposed for CTCC detection; however, they lack in vivo utility and real-time monitoring capability. Confocal backscatter and fluorescence flow cytometry (BSFC) has been used for label-free detection of CTCCs in whole blood based on machine learning (ML) enabled peak classification. Here, we expand to a deep-learning (DL) -based, peak detection and classification model to detect CTCCs in whole blood data. We demonstrate that DL-based BSFC has a low false alarm rate of 0.78 events/min with a high Pearson correlation coefficient of 0.943 between detected events and expected events. DL-based BSFC of whole blood maintains a detection purity of 72% and a sensitivity of 35.3% for both homotypic and heterotypic CTCCs starting at a minimum size of two cells. We also demonstrate through artificial spiking studies that DL-based BSFC is sensitive to changes in the number of CTCCs present in the samples and does not add variability in detection beyond the expected variability from Poisson statistics. The performance established by DL-based BSFC motivates its use for in vivo detection of CTCCs. Further developments of label-free BSFC to enhance throughput could lead to critical applications in the clinical detection of CTCCs and ex vivo isolation of CTCC from whole blood with minimal disruption and processing steps.
Open AccessDeep Learning-Enabled, Detection of Rare Circulating Tumor Cell Clusters in Whole Blood Using Label-free, Flow Cytometry
Metastatic tumors have poor prognoses for progression-free and overall survival for all cancer patients. Rare circulating tumor cells (CTCs) and rarer circulating tumor cell clusters (CTCCs) are potential biomarkers of metastatic growth, with CTCCs representing an increased risk factor for metastasis. Current detection platforms are optimized for ex vivo detection of CTCs only. Microfluidic chips and size exclusion methods have been proposed for CTCC detection; however, they lack in vivo utility and real-time monitoring capability. Confocal backscatter and fluorescence flow cytometry (BSFC) has been used for label-free detection of CTCCs in whole blood based on machine learning (ML) enabled peak classification. Here, we expand to a deep-learning (DL) -based, peak detection and classification model to detect CTCCs in whole blood data. We demonstrate that DL-based BSFC has a low false alarm rate of 0.78 events/min with a high Pearson correlation coefficient of 0.943 between detected events and expected events. DL-based BSFC of whole blood maintains a detection purity of 72% and a sensitivity of 35.3% for both homotypic and heterotypic CTCCs starting at a minimum size of two cells. We also demonstrate through artificial spiking studies that DL-based BSFC is sensitive to changes in the number of CTCCs present in the samples and does not add variability in detection beyond the expected variability from Poisson statistics. The performance established by DL-based BSFC motivates its use for in vivo detection of CTCCs. Further developments of label-free BSFC to enhance throughput could lead to critical applications in the clinical detection of CTCCs and ex vivo isolation of CTCC from whole blood with minimal disruption and processing steps.
- Open Access
Restoration of metabolic functional metrics from label-free, two-photon cervical tissue images using multiscale deep-learning-based denoising algorithms
Label-free, two-photon imaging captures morphological and functional metabolic tissue changes and enables enhanced understanding of numerous diseases. However, this modality suffers from low signal arising from limitations imposed by the maximum permissible dose of illumination and the need for rapid image acquisition to avoid motion artifacts. Recently, deep learning methods have been developed to facilitate the extraction of quantitative information from such images. Here, we employ deep neural architectures in the synthesis of a multiscale denoising algorithm optimized for restoring metrics of metabolic activity from low-SNR, two-photon images. Two-photon excited fluorescence (TPEF) images of reduced nicotinamide adenine dinucleotide (phosphate) (NAD(P)H) and flavoproteins (FAD) from freshly excised human cervical tissues are used. We assess the impact of the specific denoising model, loss function, data transformation, and training dataset on established metrics of image restoration when comparing denoised single frame images with corresponding six frame averages, considered as the ground truth. We further assess the restoration accuracy of six metrics of metabolic function from the denoised images relative to ground truth images. Using a novel algorithm based on deep denoising in the wavelet transform domain, we demonstrate optimal recovery of metabolic function metrics. Our results highlight the promise of denoising algorithms to recover diagnostically useful information from low SNR label-free two-photon images and their potential importance in the clinical translation of such imaging.
Open AccessRestoration of metabolic functional metrics from label-free, two-photon cervical tissue images using multiscale deep-learning-based denoising algorithms
Label-free, two-photon imaging captures morphological and functional metabolic tissue changes and enables enhanced understanding of numerous diseases. However, this modality suffers from low signal arising from limitations imposed by the maximum permissible dose of illumination and the need for rapid image acquisition to avoid motion artifacts. Recently, deep learning methods have been developed to facilitate the extraction of quantitative information from such images. Here, we employ deep neural architectures in the synthesis of a multiscale denoising algorithm optimized for restoring metrics of metabolic activity from low-SNR, two-photon images. Two-photon excited fluorescence (TPEF) images of reduced nicotinamide adenine dinucleotide (phosphate) (NAD(P)H) and flavoproteins (FAD) from freshly excised human cervical tissues are used. We assess the impact of the specific denoising model, loss function, data transformation, and training dataset on established metrics of image restoration when comparing denoised single frame images with corresponding six frame averages, considered as the ground truth. We further assess the restoration accuracy of six metrics of metabolic function from the denoised images relative to ground truth images. Using a novel algorithm based on deep denoising in the wavelet transform domain, we demonstrate optimal recovery of metabolic function metrics. Our results highlight the promise of denoising algorithms to recover diagnostically useful information from low SNR label-free two-photon images and their potential importance in the clinical translation of such imaging.
- 30 May 2022
- Published by SPIE-Intl Soc Optical Eng
- Vol. PC12136, 59
Label-free flow cytometric detection of circulating tumor cell clusters is enabled in whole blood samples by machine learning-based signal analysis
Circulating tumor cell clusters (CTCCs) are associated with high metastatic potential and poor patient prognosis. However, they are difficult to detect and isolate because of their extremely low numbers. Here, we report on the use of machine learning based analysis to achieve highly accurate detection of CTCCs in flowing whole blood samples relying on the confocal detection of endogenous light scattering and fluorescence signals. Our custom flow cytometer utilizes laser excitation at 405, 488, and 633 nm and confocal detection of the corresponding light scattering signals as well as fluorescence in the 525 25nm and 67020nm range. Samples consist of whole blood isolated from mice or rats spiked with varying concentrations of CTCCs consisting of 2-15 cell CTCCs, flowed through the channels of a microfluidic device. The CTCCs utilized in this initial study express GFP, so that we can detect the strong GFP signal using the 525 nm detector and use that signal as the ground truth for assessing the performance of algorithms relying on the endogenous signals detected by the other detectors. Our data is acquired during 18 independent experiments with data from 13 days used for training and five days used for testing. There are over 6,000 true positive and over 60,000 false negative peaks in this data set. We consider narrow neural network, fine k-nearest neighbors and ensemble bagged tree (EBT) models and we find that an EBT with gentle boost model yields optimal performance. Using the data from the three light scattering channels and the autofluorescence channel results in CTCC detection with purity, sensitivity, specificity and accuracy that exceed 90% in the test data. These promising results motivate further development of label-free flow cytometry using non-GFP expressing CTCCs for in vitro and in vivo applications.
- 30 May 2022
- Published by SPIE-Intl Soc Optical Eng
- Vol. PC12136, 59
Label-free flow cytometric detection of circulating tumor cell clusters is enabled in whole blood samples by machine learning-based signal analysis
Circulating tumor cell clusters (CTCCs) are associated with high metastatic potential and poor patient prognosis. However, they are difficult to detect and isolate because of their extremely low numbers. Here, we report on the use of machine learning based analysis to achieve highly accurate detection of CTCCs in flowing whole blood samples relying on the confocal detection of endogenous light scattering and fluorescence signals. Our custom flow cytometer utilizes laser excitation at 405, 488, and 633 nm and confocal detection of the corresponding light scattering signals as well as fluorescence in the 525 25nm and 67020nm range. Samples consist of whole blood isolated from mice or rats spiked with varying concentrations of CTCCs consisting of 2-15 cell CTCCs, flowed through the channels of a microfluidic device. The CTCCs utilized in this initial study express GFP, so that we can detect the strong GFP signal using the 525 nm detector and use that signal as the ground truth for assessing the performance of algorithms relying on the endogenous signals detected by the other detectors. Our data is acquired during 18 independent experiments with data from 13 days used for training and five days used for testing. There are over 6,000 true positive and over 60,000 false negative peaks in this data set. We consider narrow neural network, fine k-nearest neighbors and ensemble bagged tree (EBT) models and we find that an EBT with gentle boost model yields optimal performance. Using the data from the three light scattering channels and the autofluorescence channel results in CTCC detection with purity, sensitivity, specificity and accuracy that exceed 90% in the test data. These promising results motivate further development of label-free flow cytometry using non-GFP expressing CTCCs for in vitro and in vivo applications.
- 1 January 2022
- Published by Optica Publishing Group
- p. MW3A.3
Detection of Rare Circulating Tumor Cell Clusters in Whole Blood Using Label-free, Flow Cytometry
We demonstrate the potential of in vitro, label-free detection of Circulating Tumor Cell Clusters in whole blood using confocal backscatter and florescence flow cytometry along with a machine learning drive peak detection/classification algorithm.
- 1 January 2022
- Published by Optica Publishing Group
- p. MW3A.3
Detection of Rare Circulating Tumor Cell Clusters in Whole Blood Using Label-free, Flow Cytometry
We demonstrate the potential of in vitro, label-free detection of Circulating Tumor Cell Clusters in whole blood using confocal backscatter and florescence flow cytometry along with a machine learning drive peak detection/classification algorithm.